Scholar Rock Holding Corp. (SRRK)
58.26
+0.06
(+0.10%)
USD |
NASDAQ |
Aug 25, 16:00
58.26
0.00 (0.00%)
After-Hours: 17:04
Scholar Rock Enterprise Value : 6.789B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.789B |
| August 21, 2026 | 6.582B |
| August 20, 2026 | 6.430B |
| August 19, 2026 | 6.583B |
| August 18, 2026 | 6.366B |
| August 17, 2026 | 6.041B |
| August 14, 2026 | 6.098B |
| August 13, 2026 | 6.164B |
| August 12, 2026 | 6.256B |
| August 11, 2026 | 6.043B |
| August 10, 2026 | 6.022B |
| August 07, 2026 | 6.147B |
| August 06, 2026 | 6.113B |
| August 05, 2026 | 5.533B |
| August 04, 2026 | 5.523B |
| August 03, 2026 | 5.287B |
| July 31, 2026 | 5.463B |
| July 30, 2026 | 5.669B |
| July 29, 2026 | 5.677B |
| July 28, 2026 | 5.715B |
| July 27, 2026 | 5.662B |
| July 24, 2026 | 5.508B |
| July 23, 2026 | 5.729B |
| July 22, 2026 | 5.585B |
| July 21, 2026 | 5.899B |
| Date | Value |
|---|---|
| July 20, 2026 | 5.872B |
| July 17, 2026 | 6.140B |
| July 16, 2026 | 6.002B |
| July 15, 2026 | 6.283B |
| July 14, 2026 | 6.251B |
| July 13, 2026 | 6.363B |
| July 10, 2026 | 6.608B |
| July 09, 2026 | 6.757B |
| July 08, 2026 | 6.525B |
| July 07, 2026 | 6.589B |
| July 06, 2026 | 6.444B |
| July 02, 2026 | 6.385B |
| July 01, 2026 | 6.137B |
| June 30, 2026 | 6.400B |
| June 29, 2026 | 6.272B |
| June 26, 2026 | 6.248B |
| June 25, 2026 | 6.132B |
| June 24, 2026 | 5.958B |
| June 23, 2026 | 5.832B |
| June 22, 2026 | 5.584B |
| June 18, 2026 | 5.363B |
| June 17, 2026 | 5.318B |
| June 16, 2026 | 5.152B |
| June 15, 2026 | 5.195B |
| June 12, 2026 | 4.988B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 591.52M |
| Amgen, Inc. | 283.25B |
| Anika Therapeutics, Inc. | 272.43M |
| BioCryst Pharmaceuticals, Inc. | 2.955B |
| Imunon, Inc. | 8.399M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -109.90M |
| Total Expenses (Quarterly) | 109.90M |
| EPS Diluted (Quarterly) | -0.8414 |
| Earnings Yield | -5.92% |
| Normalized Earnings Yield | -5.893 |